Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 50 of 2228 entries
View as:

Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)

Phase: N/A Priority: Normal
NCT ID: NCT03165045 Org: User:
Start: 05/26/17 End: 03/24/19 Due: 03/24/20

This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT03325712 Org: User:
Start: 11/17/17 End: 11/26/18 Due: 11/26/19

Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02261077 Org: User:
Start: 05/31/07 End: - Due: -

A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body

Phase: N/A Priority: Normal
NCT ID: NCT03617835 Org: User:
Start: 08/16/18 End: 06/03/19 Due: 06/03/20

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00240409 Org: User:
Start: 07/31/03 End: 08/31/04 Due: 08/31/05

Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT02721875 Org: User:
Start: 04/28/16 End: 07/29/16 Due: 07/29/17

A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body

Phase: N/A Priority: Normal
NCT ID: NCT06572111 Org: User:
Start: 09/30/24 End: 12/20/25 Due: 12/20/26

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT06139341 Org: User:
Start: 07/21/23 End: 12/17/23 Due: 12/17/24

Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171507 Org: User:
Start: 05/31/06 End: - Due: -

Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02218684 Org: User:
Start: 09/30/98 End: - Due: -

Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities

Phase: N/A Priority: Normal
NCT ID: NCT00621582 Org: User:
Start: 05/31/06 End: - Due: -

Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT00619177 Org: User:
Start: 03/31/07 End: - Due: -

Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171442 Org: User:
Start: 04/30/02 End: - Due: -

All-Case Surveillance of Ofev in Patients With IPF in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02607722 Org: User:
Start: 08/31/15 End: 05/02/23 Due: 05/02/24

Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01682512 Org: User:
Start: 09/05/12 End: 10/12/16 Due: 10/12/17

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of BI 1810631 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06028464 Org: User:
Start: 09/11/23 End: 12/08/23 Due: 12/08/24

Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02187575 Org: User:
Start: 07/31/02 End: - Due: -

A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906

Phase: N/A Priority: Normal
NCT ID: NCT05751226 Org: User:
Start: 04/11/23 End: 08/01/24 Due: 08/01/25

Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain

Phase: N/A Priority: Normal
NCT ID: NCT02232555 Org: User:
Start: 05/31/05 End: - Due: -

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.

Phase: N/A Priority: Normal
NCT ID: NCT00452400 Org: User:
Start: 03/31/07 End: - Due: -

Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

Phase: N/A Priority: Normal
NCT ID: NCT01134939 Org: User:
Start: 05/31/10 End: 12/31/13 Due: 12/31/14

A Study in Healthy Men to Find Out How BI 1015550 is Taken up and Handled by the Body

Phase: N/A Priority: Normal
NCT ID: NCT04771286 Org: User:
Start: 03/25/21 End: 05/17/21 Due: 05/17/22

An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00425854 Org: User:
Start: 11/30/06 End: - Due: -

Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05130463 Org: User:
Start: 03/22/22 End: 07/08/24 Due: 07/08/25

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Phase: N/A Priority: Normal
NCT ID: NCT00294372 Org: User:
Start: 02/28/06 End: - Due: -